logo
Plus   Neg
Share
Email

Stock Alert: Adial Pharma Jumps 40% As FDA Grants EUA For COVID-19 Test

Shares of nano-cap company Adial Pharmaceuticals, Inc. (ADIL) surged nearly 40% on Tuesday morning after FDA granted emergency use authorization for the company's COVID-19 point-of-care antibody test.

ADIL is currently trading at $1.9542, up $0.5442 or 38.5958%, on the Nasdaq.

The clinical-stage biopharmaceutical company said FDA has issued an emergency use authorization for its Assure/FaStep COVID-19 IgG/IgM Rapid Test Device.

This marks the first FDA EUA for a serology (antibody) point-of-care test for COVID-19 using fingerstick blood samples as compared with current approved tests that only utilize serum, plasma, or a venous blood draw.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
After providing free and discounted rides to the polls on Election Day, Lyft is now set to support voters with discounted rides to the polls for the federal runoff races in Louisiana and Georgia. They also provided similar rides during the primary season. The ride-sharing company is continuing its Voting Access Program to provide affordable transportation to voters in need. Discount retailer Dollar General Corp. and supermarket chain Kroger Co. on Thursday reported sharp increases in their quarterly profits on higher sales. While Dollar General's results trounced analysts' estimates, Kroger's earnings beat expectations while revenue fell short. Dollar General's profit for the third quarter surged 57 percent from last year. On January 4, 2021, Discovery plans to launch its new standalone streaming service called Discovery+ which will also offer exclusive streaming access to the BBC's award-winning natural history shows like Planet Earth, Blue Planet, and Frozen Planet. The channel is expected to offer the largest content of real-life entertainment provided by any streaming platform at launch.
RELATED NEWS
Follow RTT